Balicatib
Balicatib (AAE581) is a potent and selective cathepsin K inhibitor investigated for osteoporosis treatment. It has been utilized in both in vitro enzymatic assays and in vivo preclinical studies to explore its effects on bone resorption and remodeling.
Product Specifications
CAS Number
354813-19-7
Product Name Alternative
Bone turnover, bone formation, Balicatib, AAE 581, AAE581, AAE-581, Cathepsin, Cathepsin K, dermal fibroblasts, CysteineProtease, Cysteine Protease, Inhibitor, osteoporosis, inhibit
Field of Research
Protein Biochemistry
Purity
96.80% (May vary between batches)
Solubility
DMSO:50 mg/mL (121.49 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (8.02 mM)
Smiles
CCCN1CCN (CC1) c1ccc (cc1) C (=O) NC1 (CCCCC1) C (=O) NCC#N
Molecular Formula
C23H33N5O2
Molecular Weight
411.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
353628-01 48 Tests
ACCPA (anti-cyclic citrullinated peptide antibody) BioAssayTM ELISA Kit (Rat) discontinued
Sign In for Pricing
View Details 353628-02 96 Tests
ACCPA (anti-cyclic citrullinated peptide antibody) BioAssayTM ELISA Kit (Rat) discontinued
Sign In for Pricing
View Details 